Amplo Biotechnology, Inc.
Towson, United States · Founded 2021
- Headquarters
- Towson, Maryland
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2G
- Last Round
- GrantMay 2023
About
Amplo Biotechnology is a preclinical AAV gene therapy company developing treatments for congenital myasthenic syndromes and other neuromuscular junction disorders. Their lead program AMP-101 targets Dok-7 CMS using an AAV-delivered gene replacement approach, with orphan drug designation from the FDA. The company applies a platform approach to gene therapy to address rare pediatric neuromuscular diseases with no current cure.
Summary
Amplo Biotechnology, Inc. is a Biotech company based in Towson, United States, founded in 2021. Its most recent funding was a Grant round in May 2023.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...